DENTALKART Vasa Denticity (DENTALKART) Q4 FY25 results (Jan–Mar 2025) and concall
Vasa Denticity reported robust FY25 results with 45% revenue growth to ₹251 crores and 21% EBITDA growth to ₹24.9 crores, driven by strategic investments in infrastructure, technology, and the launch of Smileworks dental lab. While these investments led to temporary margin compression and increased inventory, management expects operating leverage and margin normalization in future quarters. The company is focused on improving delivery timelines and customer retention to sustain its growth trajectory.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 59 | 63 | 73 |
| EBITDA | 6 | 6 | 7 |
| Net profit | 5 | 4 | 4 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
